News
Our highlights from 2021
What happened in and with our cluster in 2021? Here is a “pick and mix” of our many news from this year.
Felles veikart gjør veien til USA lettere
De fire helseklyngene i Norge skal fra neste år samarbeide om et veikart for bedrifter som ser mot det amerikanske markedet.
New feasibility study
The innovation district Oslo Science City releases a new feasibility study.
DIGI-B-CUBE consortium meets in Oslo
DIGI-B-CUBE aims to unlock the cross-sectoral collaborative potential of small and medium-sized companies.
Meet our new NOME coordinator
Hege Eiklid is the new coordinator of the Nordic Mentor Network for Entrepreneurship (NOME) in Norway.
Oslo Cancer Cluster is a Mature Cluster
Oslo Cancer Cluster is happy to receive the status as a Mature Cluster in the Norwegian Innovation Clusters programme.
Collaborating on patient self-monitoring
Patients report their own symptoms in a new project at Ahus, in which the university hospital collaborates with Roche and Kaiku Health.
Ultimovacs to launch new clinical study
Ultimovacs announces a new clinical study in lung cancer.
Eli Lilly & Company in the IMPRESS study
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
Lite satsing på kreftinnovasjon
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Our role as Changemaker
Did you know that Oslo Cancer Cluster is a changemaker?
NOK 16 million to new RWE company
The Research Council of Norway recently awarded grants to several innovation projects in the industrial sector. One of the lucky companies was the newcomer NordicRWE.
